Piramal Pharma Ltd
BSE:
NSE:PPLPHARMA
PPLPHARMA Share Price
BSE:
NSE:PPLPHARMA
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹31,135.19Cr
Piramal Pharma Ltd Performance
▲
▲
▲
▲
Piramal Pharma Ltd Fundamentals
Piramal Pharma Ltd Delivery and Volume
About Piramal Pharma Ltd
Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over
| Name | Designation |
|---|---|
| Nandini Piramal | Chairperson |
| PETER D DEYOUNG | Executive Director & CEO |
| Neeraj Bharadwaj | Non Executive Director |
| Jairaj Purandare | Independent Director |
| S Rama Dorai | Independent Director |
| Peter Stevenson | Independent Director |
| Sridhar Gorthi | Independent Director |
| Vibha Paul Rishi | Independent Director |
| Vivek Valsaraj | Executive Director & CFO |
| Tanya D'Costa | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Piramal Pharma Ltd FAQs
How do I Buy Piramal Pharma Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Piramal Pharma Ltd shares in BlinkX.
What is the Share Price of Piramal Pharma Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Piramal Pharma Ltd's share price is ₹230.7 as of 2025-01-15.
What is the PE ratio of Piramal Pharma Ltd?
Piramal Pharma Ltd's P/E ratio is - times as of 2025-01-15.
What is the PB ratio of Piramal Pharma Ltd?
Piramal Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 3.94, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Piramal Pharma Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Piramal Pharma Ltd's market capitalization is ₹31135.19 Cr as on 2025-01-15.
What is the ROE of Piramal Pharma Ltd?
The current financial records of Piramal Pharma Ltd show a 6.53% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Piramal Pharma Ltd?
According to Piramal Pharma Ltd's most recent financial filings, the company has a total asset value of ₹3279.44, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Piramal Pharma Ltd?
The 52-week high/low price of a Piramal Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Piramal Pharma Ltd's 52-week high and low as of 2025-01-15 are ₹237.45 and ₹229.25, respectively.
